 Palisade Bio Inc NASDAQ: PALI announced data from a Pooled-Analysis of Studies LBS-IST-POI-101 and LBS-POI-201-CN PROFILE-CN, highlighting LB1148 reduced incidence of adhesions by 72 in patients undergoing bowel resection. Studies assessed the efficacy of LB1148 to reduce the. 